Cytogenetic analysis of 298 newly diagnosed cases of acute lymphoblastic leukaemia in Tunisia
Abir Gmidène
Laboratoire de cytogénétique et de biologie de la reproduction, CHU Farhat Hached, Sousse, Tunisia
Search for more papers by this authorHlima Sennana
Laboratoire de cytogénétique et de biologie de la reproduction, CHU Farhat Hached, Sousse, Tunisia
Search for more papers by this authorHatem Elghezal
Laboratoire de cytogénétique et de biologie de la reproduction, CHU Farhat Hached, Sousse, Tunisia
Search for more papers by this authorSihem Ziraoui
Laboratoire de cytogénétique et de biologie de la reproduction, CHU Farhat Hached, Sousse, Tunisia
Search for more papers by this authorYosra Ben Youssef
Service d'hématologie, CHU Farhat Hached, Sousse, Tunisia
Search for more papers by this authorMoez Elloumi
Service d'hématologie, CHU Hédi Chaker, Sfax, Tunisia
Search for more papers by this authorLamia Issaoui
Service d'hématologie, CHU Aziza Othmana, Tunis, Tunisia
Search for more papers by this authorImed Harrabi
Service d'épidémiologie, CHU Farhat Hached, Sousse, Tunisia
Search for more papers by this authorSophie Raynaud
Laboratoire d'onco-hématologie Hôpital Pasteur, Nice, France
Search for more papers by this authorCorresponding Author
Ali Saad
Laboratoire de cytogénétique et de biologie de la reproduction, CHU Farhat Hached, Sousse, Tunisia
Laboratoire de Cytogénétique et de Biologie de la Reproduction, Hôpital Farhat Hached, avenue Ibn Eljazzar, Sousse 4000, Tunisie.Search for more papers by this authorAbir Gmidène
Laboratoire de cytogénétique et de biologie de la reproduction, CHU Farhat Hached, Sousse, Tunisia
Search for more papers by this authorHlima Sennana
Laboratoire de cytogénétique et de biologie de la reproduction, CHU Farhat Hached, Sousse, Tunisia
Search for more papers by this authorHatem Elghezal
Laboratoire de cytogénétique et de biologie de la reproduction, CHU Farhat Hached, Sousse, Tunisia
Search for more papers by this authorSihem Ziraoui
Laboratoire de cytogénétique et de biologie de la reproduction, CHU Farhat Hached, Sousse, Tunisia
Search for more papers by this authorYosra Ben Youssef
Service d'hématologie, CHU Farhat Hached, Sousse, Tunisia
Search for more papers by this authorMoez Elloumi
Service d'hématologie, CHU Hédi Chaker, Sfax, Tunisia
Search for more papers by this authorLamia Issaoui
Service d'hématologie, CHU Aziza Othmana, Tunis, Tunisia
Search for more papers by this authorImed Harrabi
Service d'épidémiologie, CHU Farhat Hached, Sousse, Tunisia
Search for more papers by this authorSophie Raynaud
Laboratoire d'onco-hématologie Hôpital Pasteur, Nice, France
Search for more papers by this authorCorresponding Author
Ali Saad
Laboratoire de cytogénétique et de biologie de la reproduction, CHU Farhat Hached, Sousse, Tunisia
Laboratoire de Cytogénétique et de Biologie de la Reproduction, Hôpital Farhat Hached, avenue Ibn Eljazzar, Sousse 4000, Tunisie.Search for more papers by this authorAbstract
Genetic changes associated with Acute Lymphoblastic Leukaemia (ALL) provide diagnostic and prognostic information with a direct impact on patient management. We report the cytogenetic analysis of 298 Tunisian patients with ALL, including 183 children and 115 adults. Chromosome abnormalities have been detected in 68.2% of our patients associating clonal numerical and/or structural rearrangements. Some chromosomal abnormalities especially hyperdiploidy, 19p13 abnormalities, 8q24 translocations, 12p, 6q deletions and TCR rearrangements occur at a lower incidence compared to that reported in other populations. ALL cases (5.7%) had miscellaneous clonal abnormalities. We also found in our Tunisian series a higher incidence for T-lineage ALL more than usually described. Among structural chromosomal abnormalities, t(9;22)(q34;q11) resulting in the BCR/ABL fusion and the t(12;21)(p13;q22) resulting in the TEL/AML1 fusion were studied by FISH providing additional diagnostic and prognostic information. We conclude that although the incidence of our cytogenetic results are slightly different, their clinical significance is similar to that described in the literature. Copyright © 2008 John Wiley & Sons, Ltd.
References
- 1 Kebriaei P, Anastasia J, Larson RA. Acute lymphoblastic leukaemia diagnosis and classification. Best Pract Res Clin Haematol 2003; 15: 597–621.
- 2 Silvia MLM, De Sanza MHO, Ribeiro RC, et al. Cytogenetic analysis of 100 consecutive newly diagnosed cases of acute lymphoblastic leukaemia in Rio de Janeiro. Cancer Genet Cytogenet 2002; 137: 85–90.
- 3 Bennett JM, Catovsky D, Daniel MT, et al. Proposal for the classification of the acute lymphoblastic leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451–458.
- 4 ISCN. In An International System for Human Cytogenetic Nomenclature. F Mitelman (ed). S. Karger: Basel, Switzerland, 2005.
- 5 Sendi SH, Elghezal H, Temmi H, et al. Cytogenetic analysis in 139 Tunisian patients with de novo acute myeloid leukaemia. Ann Genet 2002; 45: 29–32.
- 6 Zemanova Z, Michalova K, Sindelarova L, et al. Prognostic value of structural chromosomal rearrangements and small cell clones with high hyperdiploidy in children with acute lymphoblastic leukaemia. Leukemia 2005; 29: 273–280.
- 7 Kaplan EL, Meir P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
- 8
Cox DR.
Regression models and life tables.
J R Stat Soc
1972;
B34:
187–234.
10.1111/j.2517-6161.1972.tb00899.x Google Scholar
- 9 Jmili NB, Ben Abdel Aziz A, Nagara M, Mahjoub T, Ghannem H, Kortas M. Epidemiologic and cytologic profile of acute leukaemia about 193 cases in center area of Tunisia. Rev Fr Lab 2005; 2005: 23–28.
- 10 Udayakumar AM, Ahmed Bashir W, Zacharia M, et al. Cytogenetic profile of childhood acute lymphoblastic leukaemia in Oman. Arch Med Res 2007; 38: 305–312.
- 11 Gassmann W, Loffler H, Thiel E, et al. Morphological and cytochemical findings in 150 case of T lineage acute lymphoblastic leukemia in adults. German Multicenter ALL study Group (GMALL). Br J Haematol 1997; 97: 372–382.
- 12 Uckun FM, Sensel MG, Sun L, et al. Biology and treatment of childhood T-lineage acute lymphoblastic leukaemia. Blood 1998; 91: 735–746.
- 13 Fenaux P, Lai JL, Morel P, et al. Cytogenetic and their prognostic value in childhood and adult acute lymphoblastic (ALL) excluding L3. Hematol Oncol 1989; 7: 307–317.
- 14 Groupe Français de Cytogénétique Hematologique. Cytogenetic abnormalities in adult acute lymphoblastic leukaemia: correlations with hematologic findings and outcome. A collaborative study of the Groupe Français de cytogénétique Hématologique. Blood 1996; 87: 3135–3142.
- 15 Third International Workshop on Chromosomes in Leukaemia. Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukaemia. Cancer Res 1983; 43: 868–873.
- 16 Secker-Walker LM, Chessels JM, Stewart EL, Swansbury GY, Richards S, Lawler SD. Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long term follow-up. Br J Haematol 1989; 72: 336–342.
- 17 Williams DL, Raimondi SC, Rivera G, George S, Bernard CW, Murphy SB. Presence of clonal chromosome abnormalities n virtually all cases of ALL. New Engl J Med 1985; 313: 640–641.
- 18 Jarosova M, Holzerova M, Mihal V, et al. Complex karyotypes in childhood acute lymphoblastic leukaemia: cytogenetic and molecular cytogenetic study of 21 cases. Cancer Genet Cytogenet 2003; 145: 161–168.
- 19 Faderl S, Kantarjian HM, Talpaz M, Estrou Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukaemia. Blood 1998; 91: 3995–4019.
- 20 Mertens F, Johansson B, Mitelman F. Dichotomy of hyperdiploid acute lymphoblastic leukemia on the basis of the distribution of gained chromosomes. Cancer Genet Cytogenet 1996; 92: 8–10.
- 21
Moorman AV,
Clark R,
Farrell M,
Howkins JM,
Martineau M,
Secker-Walker LM.
Probes for hidden hyperdiploidy in acute lymphoblastic leukaemia.
Genes Chromosomes Cancer
1996;
16:
40–45.
10.1002/(SICI)1098-2264(199605)16:1<40::AID-GCC6>3.0.CO;2-3 CAS PubMed Web of Science® Google Scholar
- 22 Moorman AV, Harrison CJ, Buck GA, et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 2007; 109: 3189–3197.
- 23 Ma SK, Wan TSK, Chan LC. Cytogenetic and molecular genetics of childhood leukaemia. Hematol Oncol 1999; 17: 91–105.
- 24 Ritterbach J, Hiddemann W, Beck JD, et al. Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukaemia (ALL) using fluorescence in situ hybridization (FISH). Leukemia 1998; 12: 427–443.
- 25 Kurzrock R, Gutterman JU, Talpaz M. The molecular genetics of philadelphia chromosome positif leukemias. N Eng J Med 1988; 319: 990–998.
- 26 Westbrook CA, Hooberman L, Spina C, et al. Clinical significance of bcr-abl fusion gene in adult acute lymphoblastic leukaemia: a cancer and leukaemia group B study (8762). Blood 1992; 80: 2983–2990.
- 27 Lee DY, Cho HI, Kang YH, Yun SS, Park SY, Lee YS, The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies. Cancer Genet Cytogenet 2004; 152: 1–7.
- 28 Ferrando A, Look AT. Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukaemia. Semin Haematol 2000; 37: 381–395.
- 29 Schoch C, Rieder H, Freund M, Hoelzer D, Riehm H, Fonatsch C. Twenty-three cases of acute lymphoblastic leukaemia with translocation t(4;11)(q21;q23): the implication of additional chromosomal aberrations. Ann Hematol 1995; 70: 195–201.
- 30 Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukaemia. Blood Rev 2004; 18: 115–130.
- 31 Aguiar RC, Sahal J, Van Rhee F, et al. TEL-AML1 fusion in acute lymphoblastic leukaemia of adults M.R.C. Adult Leukemia working Party. Br J Haematol 1996; 95: 673–677.
- 32 Veiga LBA, Coser VM, Cavalli LR, et al. High frequency of t(12;21)(p13;q22) in children with acute lymphoblastic leukaemia and known clinical outcome in southern Brazil. Leuk Res 2004; 28: 1033–1038.
- 33 Shurtleff AS, Buijs A, Behm FG. TEL/AML1 fusion resulting from lesion in paediatric ALL and a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985–1989.
- 34 Borkhardt A, Cazzaniga G, Viehmann S. et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukaemia enrolled in the German and Italian multicenter therapy trials. Blood 1997; 90: 571–572.
- 35 Cavé H, Catheux V, Raynaud S. et al. ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphoblastic leukaemia. Leukemia 1997; 11: 1459–1464.
- 36 Plasschaert SLA, Kamps WA, Vellenga E, Devries EGE, De Bnt ESJM. Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation? Cancer Treat Rev 2004; 30: 37–51.
- 37 Forestier E, Andersen MK, Autio K, et al. Cytogenetic patterns in ETV6/RUNX1- positive pediatric B-cell precursor acute lymphoblastic leukemia: a Nordic series of 245 cases and review of the literature. Genes Chromosomes Cancer 2007; 46: 440–450.
- 38 Busson Le Coniat M, Nguyen F, Daniel MJ, Bernard AO, Berger R. Chromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukaemia. Genes Chromosomes Cancer 2001; 32: 244–249.
- 39 Golub TR, Barker GF, Bohlander SK. et al. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukaemia. Proc Natl Acad Sci USA 1995; 12: 4917–4921.